|
The additional stock offering went well with all shares sold (it appears) while the stock continued to trade higher than the offering price of 23.50. Closed at above 24. This dilution probably accounted for the price restrant. Encouraged it went as well as it did. If management uses this money well, then it will be ok. If they waste the money, then they may have blown the opportunity to replace the old pap test and dominate the market in this area. Unless their thinking is along these lines,,,,,,, |
